MANKIND PHARMA
Back to Balance Sheet
|
MANKIND PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,322 Cr | ₹4,446 Cr | ₹2,461 Cr | ₹1,780 Cr | ₹2,526 Cr |
What is the latest Net Current Assets ratio of MANKIND PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹1,322 Cr |
| Mar2024 | ₹4,446 Cr |
| Mar2023 | ₹2,461 Cr |
| Mar2022 | ₹1,780 Cr |
| Mar2021 | ₹2,526 Cr |
How is Net Current Assets of MANKIND PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,322 Cr | -70.26 | |
| Mar2024 | ₹4,446 Cr | 80.62 | |
| Mar2023 | ₹2,461 Cr | 38.25 | |
| Mar2022 | ₹1,780 Cr | -29.52 | |
| Mar2021 | ₹2,526 Cr | - | |
Compare Net Current Assets of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹97,612.6 Cr | -0.3% | -5.3% | -0.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,667.0 Cr | 1.4% | -4.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,805.0 Cr | 0.1% | -2.5% | -0.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,554.0 Cr | -2.7% | 1.2% | 39.3% | Stock Analytics | |
| CIPLA | ₹109,120.0 Cr | -2.3% | -5.3% | -9.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,920.0 Cr | -0.5% | -4.7% | -5.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -0.3% |
-5.3% |
-0.9% |
| SENSEX | 4.3% |
2.6% |
-6.4% |
You may also like the below Video Courses